Therapeutic Genome Editing Congress



Date: March 20, 2019

Location: Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA 02128

Nixon Peabody partner David Resnick will give an update on the current IP landscape surrounding CRISPR and licensing considerations for all genome editing platforms in use a therapy setting.

For more information, or to register, visit the Therapeutic Genome Editing congress website.

Back to top